Most heterotrimeric G protein ␣ subunits are covalently modified by palmitate attached to one or more N-terminal cysteine residues. Although a wide variety of proteins undergo palmitoylation, the role of this fatty acid modification in G protein signaling is not well understood. Thus, we examined the role of palmitoylation of ␣ 13 , a G protein ␣ subunit that regulates many pathways involved in cell growth. Both N-terminal cysteines at positions 14 and 18 were required for palmitoylation. Mutant ␣ 13 , in which both cysteines were changed to serines, failed to localize to plasma membranes in transfected cells and failed to activate Rho-dependent serum response factor-mediated transcription and actin stress fiber formation. However, nonpalmitoylated, cysteine to serine mutant ␣ 13 retained the ability to co-immunoprecipitate with a direct effector, p115-RhoGEF. Finally, we report the novel observation that activated ␣ 13 induces a redistribution of p115-RhoGEF from the cytoplasm to plasma membranes, but non-palmitoylated mutants of ␣ 13 fail to cause p115-RhoGEF translocation. These findings identify palmitoylation of ␣ 13 as critical for its proper membrane localization and signaling and provide insight into the mechanism of activation of Rho-dependent signaling pathways by ␣ 13 .
Heterotrimeric (␣␤␥) G proteins 1 act as molecular switches that transmit signals from heptahelical G protein-coupled receptors at the cell surface to intracellular effectors. G proteins regulate the activity of a variety of effector enzymes that generate second messengers or directly regulate other signaling proteins. Many G protein pathways propagate a signal to the nucleus, where they ultimately regulate gene expression. Accurate signal transduction in such pathways depends upon proper subcellular localization and, often, regulated changes in localization of constituent proteins.
G protein ␣ subunits (G␣) and ␤␥ subunits (G␤␥) are often found tightly associated with cellular membranes, where receptors and many effectors also reside. Membrane binding is mediated, at least in part, by covalently attached lipids (1, 2) . All G␣ are modified at their N termini by myristate and/or palmitate (3) (4) (5) (6) (7) . Myristoylation is a co-translational attachment of 14-carbon myristate to glycine at position 2 via an irreversible amide linkage. Palmitoylation, on the other hand, is a reversible post-translational attachment of 16-carbon palmitate via a thioester bond to cysteine residues. G␣ can be divided into four families, ␣ s , ␣ i , ␣ q , and ␣ 12 , based on amino acid identity, and they can also be categorized based on the type and number of N-terminal fatty acid acylations. G␣ can be myristoylated (e.g. ␣ t ), both myristoylated and palmitoylated (e.g. ␣ i , ␣ o , ␣ z ), singly palmitoylated (e.g. ␣ s , ␣ 12 ), or dually palmitoylated (e.g. ␣ q ). The reversible nature of palmitoylation makes it a particularly interesting lipid modification, and, indeed, regulation of palmitoylation has been observed for several G␣ (8) (9) (10) (11) (12) . In addition, palmitoylation, rather than myristoylation, may dictate specific targeting to plasma membranes, as opposed to intracellular membranes (13) (14) (15) . Despite much effort, very little is known regarding the biochemistry of and potential enzymes involved in palmitoylation (16) (17) (18) (19) (20) (21) The role of palmitoylation in localization and signaling functions of G␣, particularly the nonmyristoylated G␣ (␣ s , ␣ q , ␣ 12 classes), remains poorly understood. For the G␣ that are both myristoylated and palmitoylated (␣ i class), mutations that abolish both modifications result in a cytoplasmic and soluble, rather than plasma membrane-bound, protein (4, 5, (22) (23) (24) . Mutant G␣ that remain myristoylated but are no longer palmitoylated are found in both membrane and cytosolic fractions and appear to be widely distributed among intracellular membranes and plasma membranes (15) . In contrast, results are less consistent from a number of studies of the nonmyristoylated G␣. Mutations of palmitoylated cysteines in ␣ s , ␣ q , ␣ 11 , and ␣ 12 have revealed either little or no change in membrane association (10, (25) (26) (27) or a shift of most of the G␣ to soluble fractions (28, 29) . In terms of signaling activity, studies with nonpalmitoylated mutants of ␣ s , ␣ q , ␣ 11 , and ␣ 12 have consistently demonstrated a partial or complete loss of signaling in cultured cells (27) (28) (29) . Although a lack of attached palmitate on G␣ appears to result in a lack of signaling, the mechanism of this effect remains unclear. Defective signaling by cysteine mutants could be due to a failure to localize correctly at plasma membranes, an absence of palmitate-mediated protein-protein interactions, or the loss of important interactions mediated by the cysteine side chains. A goal of the studies presented here was to gain a better understanding of palmitoylation by analyzing its importance in localization and signaling by ␣ 13 .
␣ 13 , together with ␣ 12 , comprise the ␣ 12 class of G␣, and these proteins regulate a variety of pathways involved in cell growth and differentiation (30) . Cellular activities regulated by ␣ 13 include oncogenic transformation of fibroblasts, Na ϩ /H ϩ exchange, c-Jun N-terminal kinase and mitogen-activated protein kinase pathways, tyrosine phosphorylation, apoptosis, actin stress fiber formation, neurite retraction, focal adhesion assembly, and serum response element-mediated gene expression (30) . Some of these pathways require the small GTPase Rho, and indeed, ␣ 12 and ␣ 13 can stimulate the formation of active, GTP-bound RhoA in cultured cells (31) . An important connection between ␣ 13 and Rho was revealed recently by the identification of the first direct effector for ␣ 13 , a Rho-specific guanine-nucleotide exchange factor termed p115-RhoGEF (32) . Interestingly, ␣ 12 was unable to activate p115-RhoGEF, indicating that this may be an ␣ 13 -specific effector. Not only is p115-RhoGEF a direct effector for ␣ 13 , p115-RhoGEF also can regulate ␣ 13 , and to a lesser extent ␣ 12 , by virtue of an RGS domain that stimulates the GTPase activity of ␣ 13 (33) .
In this report, we show that ␣ 13 is palmitoylated at cysteine 14 and/or cysteine 18 and demonstrate a palmitoylation-dependent plasma membrane anchoring of ␣ 13 . Palmitoylation of ␣ 13 was also required for Rho-mediated serum response factor (SRF) activation and stress fiber formation. However, p115-RhoGEF interacted with both wild type and CS mutant of ␣ 13 . Furthermore, we demonstrate that p115-RhoGEF can translocate from cytoplasm to plasma membrane in response to activated ␣ 13 , but a nonpalmitoylated mutant of ␣ 13 fails to induce this translocation. These observations agree with the hypothesis that one of the major roles of palmitoylation is to tether the acylated protein(s), ␣ 13 in this case, to plasma membranes and thus allow productive protein-protein interactions, either by increasing the acylated protein's concentration in the vicinity of interacting proteins or delivering other proteins (e.g. p115-RhoGEF) to important locations in the cell.
EXPERIMENTAL PROCEDURES
Plasmid Construction-The HA epitope (DVPDYA)-tagged pcDNAIIIHA G 13 wt and pcDNAIIIHA G 13 QL were kind gifts from J. S. Gutkind (34) and will hereafter be referred to as ␣ 13 and ␣ 13 QL. ␣ 13 QL, without an epitope tag, was provided by N. Dhanasekaran. The reporter plasmid that expresses the luciferase gene under the control of a mutant serum response element lacking a ternary complex factor binding site (SRF), termed pSRF-Luc, was purchased from Stratagene. The expression vector for Myc epitope-tagged C3-transferase, pEF-Myc-C3-transferase, was a kind gift from A. Hall (35) . The plasmid encoding Myc epitope-tagged p115-RhoGEF, pEXV-Myc-p115-RhoGEF, was a gift from M. Hart (36) . The plasmids carrying HA epitope-tagged activated RhoA cDNA (RhoV14) or the ␤-galactosidase gene (pCMV-␤-gal) were obtained from P. Tsichlis (Kimmel Cancer Institute, Philadelphia). The Stratagene QuikChange Site-Directed Mutagenesis Kit was used to replace cysteines at positions 14 and 18 of ␣ 13 . We mutated both cysteines separately and dually in the wild type and QL background of ␣ 13 by using two sets of forward and reverse primers carrying base changes in appropriate codons. The forward and the reverse primers used to mutate cysteine 14 to serine to create ␣ 13 wtC14S or ␣ 13 QLC14S, were 5Ј-ccgtgctgtccgtaagcttcccgggctgc-3Ј and 5Ј-gcagcccgggaagcttacggacagcacgg-3Ј, respectively. Another set of primers, forward (5Ј-gtgtgcttcccgggctcagtactgacgaacggc-3Ј) and reverse (5Ј-gccgttcgtcagtactgagcccgggaagcacac-3Ј), were used to mutate cysteine 18 to serine to create ␣ 13 wtC18S and ␣ 13 QLC18S. The set of primers to mutate cysteine 18 to serine was utilized on C14S mutants to create double mutants, ␣ 13 wtCCSS and ␣ 13 QL CCSS. The correct DNA sequence was confirmed by DNA sequencing of the entire open reading frame (Kimmel Cancer Center Nucleic Acid Facility).
Cell Culture and Transfection-HEK293, COS, and Rat-1 cells were propagated in Dulbecco's minimal essential medium containing 10% fetal bovine serum (unless otherwise mentioned) and Gentamicin. Unless otherwise noted, cells were plated in six-well plates at 7.0 ϫ 10 5 cells per well and grown for 24 h prior to transfection. 1 g of each expression plasmid was transfected into the cells using LipofectAMINE (Life Technology Inc.) or FuGene 6 (Roche Molecular Biochemicals).
Cell Fractionation-HEK293 cells were plated at 2 ϫ 10 6 cells in 6-cm plates, grown for 24 h, and transfected with 3 g of expression plasmid. 24 h after transfection, the cells were transferred to 10-cm plates and grown for another 24 h. Particulate (P) and soluble (S) fractions were prepared from cell lysates, and expressed proteins were analyzed by immunoblotting exactly as described previously (37) . We used the anti-HA antibody (12CA5) and the anti-Myc antibody (36) to detect HA epitope-tagged proteins and Myc epitope-tagged proteins, respectively.
Immunofluorescence Localization-24 h after transfection in six-well plates, HEK293 cells were replated on glass coverslips and grown for 24 h. Cells were fixed with 3.7% formaldehyde in phosphate-buffered saline (PBS) for 15 min and permeabilized by incubation in blocking buffer (2.5% nonfat milk and 1% Triton X-100 in PBS) for 30 min. Cells were then incubated with appropriate monoclonal antibody (3 g/ml), as mentioned in each figure legend, in blocking buffer for 1 h. The cells were washed with blocking buffer and incubated for 30 min in a 1:100 dilution of a fluorescently labeled secondary antibody. Donky antimouse antibodies labeled with Texas Red or fluorescein isothiocyanate (Jackson Immunoresearch, West Grove, PA) and goat anti-mouse antibodies labeled with Alexa488 (Molecular Probes, Inc., Eugene, OR) were used. The coverslips were washed with 1% Triton X-100 in PBS, rinsed in distilled water, and mounted on glass slides with 10 l of Prolong Antifade reagent (Molecular Probes, Inc.). Microscopy was performed with an Olympus BX60 microscope equipped with a 60X/NA1.4 objective. Images were recorded with a Sony DKC-5000 digital camera and transferred to Adobe Photoshop for digital processing.
Metabolic Labeling and Immunoprecipitation-Radiolabeling with [9,10- 3 H]palmitic acid (NEN Life Science Products) was performed exactly as described (37) .
SRF-mediated Luciferase Gene Transcription Assay-COS cells (4 ϫ 10 5 ) were plated in 24-well plates and grown for 24 h. Cells were then switched to serum-free medium (with antibiotic) and transfected, using FuGene 6, with pCMV-␤-gal (0.12 g), pSRF-Luc (0.12 g), and other plasmids as indicated. After 24 h of transfection, cells were carefully washed twice with cold PBS and were lysed by using reporter lysis buffer (Promega). 20 l of each lysate was mixed at room temperature with 50 l of luciferase substrate (Promega), and luciferase activities were determined by measuring luminescence intensity. Lysates were assayed for ␤-galactosidase activity by the colorimetric method and were used to normalize transfection efficiency.
Actin Stress Fiber Formation Assay-After allowing Rat-1 cells to attach to coverslips, the culture medium was changed to Dulbecco's minimal essential medium plus 0.1% fetal bovine serum. 24 h later, the culture medium was changed to Dulbecco's minimal essential medium without serum. 24 h after that, the cells on coverslips were transfected using FuGene 6 (Roche Molecular Biochemicals). Cells were then fixed with 3.7% formaldehyde 24 h after transfection. Coverslips were prepared for fluorescence microscopy, as described under "Immunofluorescence Localization," with the exception that a 1:40 dilution of Alexa594 conjugated to phalloidin (Molecular Probes) was included during the secondary antibody incubation to detect actin fibers Co-immunoprecipitation and Western Blot Analysis-HEK293 cells were transfected according to the earlier described protocol, with plasmid encoding Myc epitope-tagged p115-RhoGEF together with plasmids encoding HA epitope-tagged ␣ 13 , ␣ 13 QL, ␣ 13 CCSS, and ␣ 13 QL CCSS. After transfection, cells were washed twice with cold PBS and were lysed at 4°C in 1 ml of buffer containing 25 mM HEPES, pH 7.5, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 1% Triton X-100, 0.5% sodium deoxycholate, 10 M AlCl 3 , 10 mM sodium fluoride, 20 mM ␤-glycerophosphate, 1 mM sodium vanadate, 1 mM phenylmethylsulfonyl fluoride, 20 g/ml aprotinin, and 20 g/ml leupeptin. Lysates were centrifuged at 500 ϫ g for 10 min at 4°C. HA epitope-tagged ␣ 13 and its mutants were immunoprecipitated from the cleared lysates by incubating for 1 h at 4°C with anti-HA antibody. Immunocomplexes were recovered with the aid of Protein A/G PLUS agarose (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Lysates and the immunocomplexes were analyzed by immunoblotting with appropriate monoclonal antibody as mentioned in each figure legend. In our experiments, we utilized anti-HA epitope (12CA5) and anti-Myc epitope (32) mouse monoclonal antibodies.
RESULTS

Cysteine 14 and Cysteine 18
Are Required for Palmitoylation of ␣ 13 -Inspection of the amino acid sequence of ␣ 13 ( Fig. 1 ) identified cysteine 14 and/or cysteine 18 as potential sites for palmitoylation. To test this prediction, we mutated the appropriate codons to replace cysteines 14 and 18 with serines, either individually (␣ 13 C14S and ␣ 13 C18S) or doubly mutated (␣ 13 CCSS). The double cysteine to serine mutant was also created in ␣ 13 QL (␣ 13 QL CCSS), a constitutively active form of ␣ 13 in which a conserved glutamine at position 226 is replaced with a leucine (38) . To facilitate immunoprecipitation and immunolocalization and to easily distinguish transfected ␣ 13 from endogenous G protein ␣ subunits, ␣ 13 and its mutants described here also contained a HA epitope tag at the N termini. The presence of the HA tag does not affect the ability of ␣ 13 QL to activate signaling pathways (34) (Fig. 5) , nor does it prevent palmitoylation of ␣ 13 ( Fig. 2) .
[ Fig. 2A , lane 6) incorporated radiolabeled palmitate. This is consistent with the previously described incorporation of radiolabeled palmitate into ␣ 13 after expression in insect cells (39) . Importantly, the single ( Fig. 2A , lanes 3 and 4) and double cysteine to serine mutants ( Fig. 2A , lanes 5 and 7) of ␣ 13 failed to incorporate detectable levels of radiolabeled palmitate. Fig. 2B shows that similar levels of ␣ 13 proteins were immunoprecipitated from the cell extracts. This result suggests that both cysteine 14 and cysteine 18 are required for efficient palmitoylation of ␣ 13 and are probably the sites of covalent attachment of palmitate. A long exposure of an additional palmitate-labeling experiment confirms the lack of palmitoylation of the single and double cysteine mutants (Fig.  2C ). The failure of the single cysteine to serine mutants, ␣ 13 C14S and ␣ 13 C18S, to incorporate palmitate is similar to a previous study with ␣ q (28) . Like ␣ 13 , two N-terminal cysteines, at positions 9 and 10, were required for palmitoylation of ␣ q ; single cysteine to serine mutants of ␣ q incorporated very low levels of radiolabeled palmitate.
Palmitoylation Is Critical for ␣ 13 Plasma Membrane Targeting-To determine the role of palmitoylation in proper membrane localization of ␣ 13 , we assayed the subcellular localization of ␣ 13 and its palmitoylation-deficient cysteine to serine mutants. Immunofluorescence microscopy of transiently transfected 293 cells demonstrated the importance of palmitoylation for plasma membrane localization of ␣ 13 . Wild type ␣ 13 was detected predominantly at plasma membranes, as shown by bright staining at the cell periphery (Fig. 3, wt) . However, both of the single cysteine mutants, ␣ 13 C14S (Fig. 3, C14S ) and ␣ 13 C18S (Fig. 3, C18S) , and the double cysteine mutant, ␣ 13 CCSS (Fig. 3, CCSS) , exhibited no detectable plasma membrane staining but instead displayed a diffuse cytoplasmic staining. These results indicate that preventing palmitoylation by cysteine to serine mutations blocks the ability of ␣ 13 to stably bind to plasma membranes.
To extend this analysis of subcellular localization, ␣ 13 and its mutants were assayed for their presence in membrane-containing and cytosolic fractions after cell lysis. Transfected HEK293 cells were lysed in a hypotonic buffer, and cellular proteins were separated into particulate (P) or soluble (S) fractions by high speed centrifugation. Immunoblotting indicated that ␣ 13 partitioned almost exclusively into the particulate fraction (Fig. 4) , suggesting that ␣ 13 is tightly bound to cellular membranes in agreement with our immunofluorescence microscopy results (Fig. 3) . The CCSS mutants of ␣ 13 displayed pronounced increases in the soluble fractions (S) (Fig. 4B) . Fig. 4A , a graphical representation of three cellular fractionation experiments, demonstrates that the distribution of ␣ 13 (98:2, P:S) and ␣ 13 QL (92:8, P:S) has shifted to 47:53 (P:S) and 50:50 (P:S) for ␣ 13 CCSS and ␣ 13 QL CCSS, respectively. This increased partitioning into the cytosol by the ␣ 13 cysteine to serine mutants is consistent with their lack of palmitoylation (Fig. 2) and immunofluorescence microscopy indicating a cytoplasmic localization (Fig. 3) .
␣ ]palmitic acid in 6-cm dishes. ␣ 13 proteins were immunoprecipitated by using the 12CA5 antibody against the HA epitope. Immunoprecipitated proteins were subjected to SDS-polyacrylamide gel electrophoresis, and identical gels were subjected to fluorography (A, 30-day exposure) and immunoblotting (B) with 12CA5 antibody. C, a fluorogram of a long exposure (20 weeks) of a separate experiment. 
FIG. 3.
Immunofluorescence microscopy localization of ␣ 13 and CS mutants. HEK293 cells were transfected with plasmids encoding HA-tagged wild type ␣ 13 (wt), ␣ 13 C14S (C14S), ␣ 13 C18S (C18S), or ␣ 13 CCSS (CCSS). 48 h after transfection, cells were fixed with 3.7% para-formaldehyde. Cells expressing ␣ 13 proteins were incubated with 12CA5 antibody, followed by staining with fluorescein isothiocyanatelabeled secondary antibody. Expressed ␣ 13 proteins were visualized by fluorescence microscopy, as described under "Experimental Procedures." More than 100 cells were examined in at least three experiments, and Ͼ95% of the cells showed staining patterns similar to the images presented here. (27) . Cysteine 14 and 18 in ␣ 13 were mutated to serine in this study. evident that ␣ 13 can mediate activation of the small G protein RhoA by certain G protein-coupled receptors (e.g. the lysophosphatidic acid receptor) (40) . In addition, constitutively active forms of ␣ 13 can stimulate RhoA and RhoA-dependent signaling pathways. Thus, we investigated two Rho-dependent signaling end points to test the signaling ability of CS mutants of ␣ 13 . To examine signaling functions of ␣ 13 in a receptor-independent manner, ␣ 13 QL was compared with ␣ 13 QL CCSS.
First, we assayed the ability of ␣ 13 QL or ␣ 13 QL CCSS to activate SRF-mediated gene transcription (41) . Activation of gene transcription was evaluated in a transient transfection assay employing a reporter plasmid containing a serum response element that binds SRF and promotes the transcription of a luciferase gene. Expression of activated forms of ␣ 13 markedly stimulated the production of the reporter luciferase (Fig.  5) . Both the HA-tagged ␣ 13 QL (34), used throughout this report, and nontagged ␣ 13 QL activated transcription similarly (Fig. 5) , indicating that the presence of the HA epitope tag is not detrimental to signaling by ␣ 13 QL. Additionally, a constitutively active form of RhoA (RhoV14), in which glycine 14 has been changed to valine, stimulated SRF-mediated transcription. Wild type ␣ 13 (HA-tagged ␣ 13 ) consistently produced not more than 2-fold SRF stimulation over the control (data not shown). ␣ 13 QL-induced and RhoV14-induced transcription was inhibited by co-expression of Clostridium botulinum C3-transferase (C3), a toxin that inactivates Rho by catalyzing its ADPribosylation, thus confirming the Rho dependence of this ␣ 13 QL signaling pathway (41) . Importantly, ␣ 13 QL CCSS was unable to induce SRF-dependent luciferase gene transcription (Fig. 5) . Likewise, the single cysteine mutants, ␣ 13 QL C14S and ␣ 13 QL C18S, failed to signal in this assay (data not shown). These observations suggest the importance of palmitoylation of ␣ 13 for proper signaling.
The second Rho-dependent signaling assay that we used to evaluate ␣ 13 QL and ␣ 13 QL CCSS function was the promotion of actin stress fiber formation (42) . Stress fibers were visualized by staining transiently transfected Rat-1 cells with fluorescently labeled phalloidin, a mushroom toxin known to bind actin fibers irreversibly. After serum starvation, the cells displayed a low basal level of stress fibers. However, transfection of ␣ 13 QL (Fig. 6a) or RhoV14 (Fig. 6c) induced dramatic actin stress fiber formation. Wild type ␣ 13 did not induce stress fibers (data not shown). Co-transfection of the C3-transferase plasmid completely abolished stress fiber induction in cells overexpressing ␣ 13 QL (Fig. 6g) or RhoV14 (Fig. 6i) , consistent with previous reports (43) . Cells expressing ␣ 13 QL CCSS showed no increase in stress fiber formation (Fig. 6b) , consistent with its lack of activation of SRF-mediated gene transcription. Thus, these two assays demonstrate that nonpalmitoylated mutants of ␣ 13 are unable to promote Rho-dependent signaling.
Cysteine to Serine Mutants of ␣ 13 Co-immunoprecipitate with p115-RhoGEF-To understand further the lack of signaling by palmitoylation-deficient ␣ 13 , we considered the two following possibilities. 1) Loss of signaling by ␣ 13 QL CCSS could result from an inability to interact with effector due to the loss of a palmitate-mediated or cysteine-mediated protein-protein interaction, or 2) loss of signaling may be caused primarily by its inability to reside at plasma membranes and propagate a signal there. We tested the former possibility by assaying the ability of mutant ␣ 13 to interact with p115-RhoGEF by coimmunoprecipitation. Recently, p115-RhoGEF was identified as a direct effector for ␣ 13 (32) . It was demonstrated that activated ␣ 13 co-immunoprecipitated with p115-RhoGEF from cell extracts, and, using purified proteins, ␣ 13 could directly bind to p115-RhoGEF and stimulate its ability to promote GTP for GDP exchange in Rho. Thus, these results suggested that p115-RhoGEF functions as a direct link between ␣ 13 and Rho (32) .
p115-RhoGEF was co-expressed with ␣ 13 or ␣ 13 mutants, and the expressed ␣ 13 proteins were immunoprecipitated after cell lysis. Co-immunoprecipitation of p115-RhoGEF was detected by immunoblotting the immunoprecipitates with an antibody directed against the Myc epitope tag on p115-RhoGEF (36). As expected (32), p115-RhoGEF was detected in immunoprecipitates of ␣ 13 or ␣ 13 QL (Fig. 7A) , suggesting that p115-RhoGEF interacts with ␣ 13 . Because this interaction is dependent on the activation state of ␣ 13 (32, 33) (data not shown), aluminum fluoride, a reagent that activates G protein ␣ subunits (44, 45) , was added to cell extracts. Importantly, p115-RhoGEF was also detected in immunoprecipitates of the nonpalmitoylated mutants ␣ 13 CCSS and ␣ 13 QL CCSS (Fig. 7A) . Similar levels of ␣ 13 were immunoprecipitated in each case (Fig. 7B) , and co-transfected cells expressed similar amounts of p115-RhoGEF (Fig.  7c) . These observations argue against possibility 1, suggesting instead that nonpalmitoylated ␣ 13 retains its ability to interact with an important effector, and cysteine to serine mutations at the positions 14 and 18 do not affect ␣ 13 interaction with p115-RhoGEF. Furthermore, the ability of ␣ 13 CCSS to co-immunoprecipitate with p115-RhoGEF in an aluminum fluoridedependent manner (data not shown) suggests that the CCSS mutation does not affect the ability of ␣ 13 to undergo activationdependent conformational change.
␣ 13 QL, but Not ␣ 13 QL CCSS, Induces Translocation of p115-RhoGEF from Cytoplasm to Plasma Membrane-Although ␣ 13 QL CCSS was defective in Rho-mediated signaling (Figs. 5 and 6), our observations that constitutively active ␣ 13 (␣ 13 QL) and the cysteine to serine mutant of ␣ 13 QL (␣ 13 QL CCSS) interacted with p115-RhoGEF (Fig. 7) led us to consider further the idea that the major role of ␣ 13 palmitoylation is to direct and/or tether ␣ 13 to plasma membranes (possibility 2). To extend this analysis, we speculated that ␣ 13 -mediated Rho signaling may also require plasma membrane localization of the direct effector molecule, p115-RhoGEF, and p115-RhoGEF's localization may be dependent on ␣ 13 palmitoylation and plasma membrane targeting. To examine this hypothesis, we co-expressed Myc epitope-tagged p115-RhoGEF with HA epitope-tagged ␣ 13 , ␣ 13 QL, or ␣ 13 QL CCSS. Cells were subjected to indirect immunofluorescence analysis by using antiMyc antibody to detect p115-RhoGEF in the cells (Fig. 8, Myc) and using anti-HA antibody to detect ␣ 13 proteins in the cells (Fig. 8, HA) . p115-RhoGEF is predominantly cytoplasmic when expressed with vector alone (data not shown) or with ␣ 13 (Fig.  8a) . On the other hand, p115-RhoGEF is translocated to the plasma membrane when co-expressed with ␣ 13 QL, as visualized by bright staining at the periphery of cells (Fig. 8b) . Interestingly, cytoplasmic staining of p115-RhoGEF remains unaltered when co-expressed with ␣ 13 QL CCSS (Fig. 8c) , indicating that nonpalmitoylated ␣ 13 is unable to promote FIG. 7 . ␣ 13 and CCSS mutants of ␣ 13 co-immunoprecipitate with p115-RhoGEF. HEK293 cells were transfected with plasmid encoding Myc epitope-tagged p115-RhoGEF together with plasmid encoding HA-tagged ␣ 13 , ␣ 13 QL, ␣ 13 CCSS, or ␣ 13 QL CCSS. Cell lysates, prepared as described under "Experimental Procedures," were immunoprecipitated with 12CA5 antibody against the HA epitope. Immunoprecipitates were subjected to immunoblot analysis using antibody against the Myc epitope (A) to detect co-immunoprecipitation of p115-RhoGEF and using antibody against the HA epitope (B) to detect immunoprecipitated ␣ 13 proteins. C, immunoblot of the lysates using anti-Myc antibody to detect expression of p115-RhoGEF protein. , h, and k) , or RhoV14 (c, f, i, and l) with (g-l) or without (a-f) cotransfecting a plasmid encoding C3-transferase. 24 h after transfection, cells were fixed and stained with Alexa594-conjugated phalloidin along with 12CA5 antibody followed by Alexa488 goat antimouse antibody, as described under "Experimental Procedures." Phalloidin staining detected actin stress fibers (a-c and  g-l) , and the 12CA5 antibody (HA) identified cells expressing ␣ 13 QL (d and j), ␣ 13 QL CCSS (e and k) or RhoV14 (f and l). All images of phalloidin-stained cells were obtained with identical camera settings. More than 50 cells were examined in at least two experiments, and Ͼ80% of the cells showed staining patterns similar to the images presented here.
plasma membrane localization of p115-RhoGEF. ␣ 13 is plasma membrane-bound (Fig. 8d) as expected. ␣ 13 QL is consistently observed in the plasma membranes with substantial cytoplasmic staining (Fig. 8e) , while ␣ 13 QL CCSS, like ␣ 13 CCSS (Fig. 3) appears completely cytoplasmic.
The subcellular distribution of p115-RhoGEF was also assayed by separating cell lysates into particulate (P) and soluble (S) fractions, and the results were consistent with and extended the immunofluorescence analysis (Fig. 8) . Immunoblotting with anti-Myc antibody (Fig. 9A ) demonstrated that p115-RhoGEF is almost exclusively in the cytosolic (S) fraction when co-expressed with vector alone (data not shown) or with ␣ 13 (Fig. 9A, wt) . When co-expressed with ␣ 13 QL, p115-RhoGEF was shifted substantially into the particulate fraction (40 -50% of total P ϩ S) (Fig. 9A, QL) . No shift of p115-RhoGEF to the particulate (P) fraction was observed when co-expressed with ␣ 13 QL CCSS (Fig. 9A, QL,CCSS) , although a substantial amount of ␣ 13 QL CCSS was present in the particulate fraction (Fig. 9B, QL,CCSS) . Immunoblotting of the same fractions with anti-HA antibody demonstrated that the partitioning of ␣ 13 wt, ␣ 13 QL, and ␣ 13 QL CCSS was unaltered by p115-Rho-GEF co-expression (Fig. 9B) ; the distribution of ␣ 13 proteins agrees with our earlier subcellular fractionation data (Fig. 4) . Thus, consistent with the proposal that palmitoylation-dependent plasma membrane targeting of ␣ 13 is required for its signaling through Rho-dependent pathways, these experiments demonstrate that ␣ 13 QL induces a redistribution of p115-Rho-GEF from cytoplasm to plasma membranes and that nonpalmitoylated ␣ 13 QL CCSS is unable to effect a translocation of p115-RhoGEF.
DISCUSSION
In this report, we have mutated N-terminal cysteine residues in ␣ 13 to identify sites of palmitoylation and to analyze the importance of ␣ 13 palmitoylation for plasma membrane localization and signaling. In addition, we have analyzed the ability of wild type and mutant ␣ 13 to interact with and affect the subcellular localization of p115-RhoGEF, a protein that is both an effector and regulator of ␣ 13 . Specifically, we demonstrate that 1) palmitoylation is required for ␣ 13 plasma membrane localization; 2) nonpalmitoylated CS mutants of ␣ 13 cannot activate Rho-dependent signaling pathways; 3) nonpalmitoylated mutants of ␣ 13 retain the ability to interact, via coimmunoprecipitation, with p115-RhoGEF; 4) activated ␣ 13 QL can induce the translocation of p115-RhoGEF from cytoplasm to plasma membranes, but nonpalmitoylated ␣ 13 QL CCSS cannot cause redistribution of p115-RhoGEF.
The Role of Palmitoylation in ␣ 13 Membrane Binding-The data presented here are consistent with a model in which covalently attached palmitate serves as a hydrophobic membrane anchor for G␣ and, additionally, provides a specific signal to target G␣ to plasma membranes. For a number of peripheral membrane proteins, including other G␣, Ha-Ras, and Src family tyrosine kinases (1, 46) , palmitoylation has been shown to be critical for tight membrane binding. All G␣, with the exception of transducin (␣ t ) and gustducin (␣ gust ) contain one or more cysteines within the N-terminal 20 amino acids that appear to be sites for palmitoylation. Members of the ␣ i family of G␣ all contain the N-terminal sequence MGC in which glycine 2 is myristoylated and cysteine 3 is palmitoylated; however, for the nonmyristoylated G␣ (i.e. ␣ s , ␣ q , and ␣ 12/13 families), amino acids surrounding the palmitoylated cysteines show very little sequence similarity. ␣ 13 is most identical to ␣ 12 (65% amino acid identity), and ␣ 13 and ␣ 12 appear to perform very similar signaling functions. Despite this similarity, ␣ 13 and ␣ 12 have quite different N termini. ␣ 13 has a shorter N terminus and two apparent cysteine sites of palmitoylation, whereas ␣ 12 has only one palmitoylated cysteine ( Fig. 1) (27) . These differences may influence their signaling properties by allowing differences in subcellular localization and ability to interact with other proteins. The importance of palmitoylation for membrane localization of G␣, particularly the nonmyristoylated G␣, has been controversial. Based on crude fractionation experiments, some investigators have observed dramatic loss of membrane binding by overexpressed, nonpalmitoylated mutants of ␣ s , ␣ q , or ␣ 11 (28, 29) , while others have detected little or no change in membrane binding of mutant ␣ s , ␣ q , or ␣ 12 (10, (25) (26) (27) . Although the differences may be due to technical variations in expression levels or cell type, our results with ␣ 13 highlight the importance of assaying membrane localization in multiple ways. Cell fractionation demonstrated only a partial shift of ␣ 13 CCSS to cytosol (Fig. 4) , but immunofluorescence microscopy results suggested a loss of specific plasma membrane localization by ␣ 13 CCSS (Fig. 3) . By comparison, subcellular localization by immunofluorescence microscopy has not been described for other nonmyristoylated G␣ CS mutants that retain association with particulate fractions. Such studies may reveal a consistent role for covalently attached palmitate in targeting G␣ to cellular plasma membranes; it is possible that observed differences in G␣ CS mutants may reflect differences in associations with intracellular membrane compartments or different degrees of association with particulate fractions after cell lysis. Indeed, crude fractionation of a nonacylated mutant of Gpa1, a Saccharomyces cerevisiae G␣, indicated complete association (a-c) , and on a separate coverslip, ␣ 13 proteins were detected by indirect immunofluorescence using antibody against HA epitope (d-f). More than 100 cells were examined in at least three experiments, and Ͼ95% of the cells showed staining patterns similar to the images presented here.
with particulate fractions; however, more detailed subcellular fractionation revealed a dramatic shift of the mutant Gpa1 out of plasma membrane-containing fractions and into fractions containing intracellular membranes (47) . Presently, our observations cannot distinguish between a completely soluble cytoplasmic localization of ␣ 13 CCSS and a functionally relevant association with intracellular membranes or structures.
Activation by ␣ 13 of Rho-dependent Signaling PathwaysConsistent with studies of other G␣ CS mutants showing loss of signaling function, ␣ 13 CCSS was defective in activating Rhodependent signaling (Figs. 5 and 6 ). For the nonmyristoylated G␣ members, palmitoylation site mutants of ␣ s , ␣ q , ␣ 11 , and ␣ 12 have been shown to display a decreased or complete lack of signaling ability (27) (28) (29) . ␣ 13 appears to mediate signaling pathways very similar to those activated by ␣ 12 , although important differences have been noted (30) . A recent study showed that a nonpalmitoylated CS mutant of ␣ 12 was unable to cause transformation of NIH3T3 cells (27) , in agreement with our results showing a lack of signaling by ␣ 13 CCSS. Probably, signaling through the Rho family of proteins is essential for cellular oncogenic transformation induced by ␣ 12 and ␣ 13 (30, 48) .
The studies described here also provide insight into the mechanism of how palmitoylation regulates signaling by ␣ 13 and, by inference, signaling by G␣ in general. The ability of ␣ 13 and ␣ 13 CCSS to co-immunoprecipitate with p115-RhoGEF (Fig. 7) in an activation-dependent manner suggests that mutant nonpalmitoylated ␣ 13 retains the ability to interact with this effector. Because purified ␣ 13 and p115-RhoGEF interact in vitro (33) , it is likely that co-immunoprecipitation of the two proteins (32) represents a direct protein-protein interaction. Although ␣ 13 CCSS and p115-RhoGEF interacted (Fig. 7) , activated ␣ 13 CCSS was incapable of activating gene transcription and stress fiber formation ( Fig. 5 and 6 ), two assays of Rho-dependent signaling. Taken together, these results suggest that palmitoylation serves primarily to target ␣ 13 to its correct subcellular destination, where it can propagate a signaling pathway. Our observations suggest that neither attached palmitate nor cysteine side chains at positions 14 and 18 are required to mediate protein-protein interactions between ␣ 13 and p115-RhoGEF, but, rather, palmitoylation of ␣ 13 is important for its proper localization and, by extension, proper localization of p115-RhoGEF, as discussed below.
Although co-immunoprecipitation experiments suggest that palmitate attached to ␣ 13 does not mediate interactions with p115-RhoGEF, palmitoylation may play a role in regulating ␣ 13 interactions with other proteins. Palmitoylation is a reversible covalent modification, and, potentially, palmitate could prevent certain protein-protein interactions (i.e. depalmitoylation may allow important interactions to occur). For ␣ z , a G␣ that is normally myristoylated and palmitoylated, it was demonstrated that the depalmitoylated form is the preferred substrate for RGSZ1, a GTPase-activating protein that exhibits selectivity toward ␣ z (49) . It remains to be tested whether p115-RhoGEF, like RGSZ1, prefers depalmitoylated ␣ 13 when acting as a GTPase-activating protein. Whether different binding determinants on p115-RhoGEF mediate ␣ 13 activation of Rho guanine nucleotide exchange activity versus regulation of ␣ 13 by its GTPase-activating protein activity remains to be determined.
Further insight into the mechanism of ␣ 13 signaling was obtained by our observation that activated ␣ 13 induced a redistribution of p115-RhoGEF from the cytoplasm to plasma membranes (Figs. 8 and 9 ). Although translocation of cytoplasmic proteins to plasma membrane-bound signaling complexes has emerged as a hallmark of tyrosine kinase-mediated signaling pathways (50), the results described here suggest that some G␣ may function similarly. It is not yet clear whether plasma membrane localization of p115-RhoGEF is required to mediate activation of Rho by ␣ 13 , but our results with ␣ 13 QL CCSS are consistent with this proposal. Although capable of interacting with p115-RhoGEF (Fig. 7) , ␣ 13 QL CCSS did not activate SRFmediated gene transcription (Fig. 5 ) and stress fiber formation (Fig. 6 ). ␣ 13 QL CCSS also failed to promote plasma membrane localization of p115-RhoGEF (Figs. 8 and 9 ).
Recent reports describing the subcellular localization of RhoA provide further support for the proposal that ␣ 13 -dependent plasma membrane localization of p115-RhoGEF is important for activating Rho signaling pathways. Wild type RhoA was found predominantly in the cytosol, but a constitutively active mutant of RhoA localized to plasma membranes (31) . Moreover, the addition of lysophosphatidic acid to cells has been shown to induce a translocation of RhoA from the cytoplasm to plasma membranes (31, 51) . Although the mechanism of RhoA translocation to plasma membranes has not been elucidated, binding to plasma membrane-bound p115-RhoGEF may be an important determinant. According to this model, exchange of GDP for GTP on rhoA, catalyzed by p115-RhoGEF, would occur at plasma membranes.
Subcellular Localization of Other rhoGEF and RGS Proteins-p115-RhoGEF is a member of a subfamily of DH and PH domain-containing proteins (48) that display guanine nucleotide exchange factor activity that is specific for Rho, as opposed to the related small GTPases Rac and Cdc42 (36) . The other FIG. 9 . Activated ␣ 13 , but not its CCSS mutant, induces translocation of p115-RhoGEF from soluble to particulate fractions in HEK293 cells. Myc epitope-tagged p115-RhoGEF was coexpressed with HA epitope-tagged ␣ 13 (wt), ␣ 13 QL (QL), or ␣ 13 QL CCSS (QL-,CCSS). Expressed proteins were separated from the cell lysates into particulate (P) and soluble (S) fractions by high speed centrifugation. P and S fractions were subjected to immunoblot analysis using anti-Myc antibody to detect p115-Rho-GEF (A) and anti-HA-antibody to detect ␣ 13 proteins (B). Three independent experiments showed a similar translocation pattern of p115-RhoGEF. members of this subfamily are Lbc, Lfc, Lsc, and probably the recently described PDZrhoGEF. Co-transfection experiments utilizing dominant negative mutants have implicated PDZrho-GEF (34) and Lbc (52) in coupling ␣ 12 and ␣ 13 to Rho, although direct activation of their rhoGEF activity by ␣ 12 and ␣ 13 remains to be tested using purified proteins. For Lfc, Lbc, and p115-RhoGEF, deletion of their PH domains blocked transforming activity (36, 53, 54) . However, the addition of an isoprenylation motif to the PH domain-deleted Lfc restored its transforming activity, suggesting that the PH domain plays a role in targeting Lfc to membranes, and this membrane localization is required for signaling (53) . It will be interesting to determine whether the PH domain of p115-RhoGEF is required for its ␣ 13 -dependent plasma membrane targeting.
p115-RhoGEF is also a member of the large and growing family of RGS proteins. It is assumed that RGS proteins must localize, at least temporarily, to plasma membranes in order to act on G␣ that reside there. RGS proteins have been identified in a variety of subcellular locations and appear to utilize diverse mechanisms, including a transmembrane domain, palmitoylation, and amphipathic helices, to bind cellular membranes (55, 56) . Particularly noteworthy in regard to the results with p115-RhoGEF presented here, RGS3 and RGS4 have been shown to translocate from cytoplasm to plasma membranes in response to G protein activation. RGS4 was shown to translocate from the cytoplasm to plasma membranes upon co-transfection of constitutively active ␣ i2 (57) , while RGS3 showed a similar redistribution in response to constitutively active ␣ 11 or the G protein-coupled receptor agonist endothelin (58) . A mutant RGS4 that does not interact with ␣ i2 also translocated to plasma membranes (57) . This result suggests that direct binding to constitutively active ␣ i2 is not responsible for the induced plasma membrane binding of RGS4; the effect of constitutively active ␣ i2 is somehow indirect (57) . RGS4 is one of the smaller members of the RGS family with no recognizable domains outside of the conserved RGS box. RGS3 contains approximately 400 amino acids N-terminal to the RGS box. When this N-terminal domain was expressed, it too redistributed to plasma membranes in response to endothelin, although the RGS domain was absent (58) . Thus, both of these studies suggest that movement of RGS proteins from cytoplasm to membranes is a complex process involving more than just G␣-RGS interactions. Likewise, it will be important to determine the domains of p115-RhoGEF that are sufficient for our observed ␣ 13 -dependent plasma membrane targeting.
In conclusion, the studies reported here highlight the importance of palmitoylation of ␣ 13 for proper localization and signaling. In addition the use of nonpalmitoylated mutants of ␣ 13 has provided insight into the cellular mechanisms of ␣ 13 activation of the small GTPase Rho.
